Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma.

Br J Dermatol 2018 Nov 14;179(5):1088-1094. Epub 2018 Aug 14.

Department of Dermatology, Massachusetts General Hospital, Boston, MA, U.S.A.

Background: Many antihypertensive drugs (ADs) are photosensitizing, heightening reactivity of the skin to sunlight. Photosensitizing ADs have been associated with lip cancer, but whether they impact the risk of cutaneous squamous cell carcinoma (cSCC) is unknown.

Objectives: To examine the association between AD use and cSCC risk among a cohort of non-Hispanic white individuals with hypertension enrolled in a comprehensive integrated healthcare delivery system in northern California (n = 28 357).

Methods: Electronic pharmacy data were used to determine exposure to ADs, which were classified as photosensitizing, nonphotosensitizing or unknown, based on published literature. We identified patients who developed a cSCC during follow-up (n = 3010). We used Cox modelling to estimate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs). Covariates included age, sex, smoking, comorbidities, history of cSCC and actinic keratosis, survey year, healthcare utilization, length of health plan membership and history of photosensitizing AD use.

Results: Compared with nonuse of ADs, risk of cSCC was increased with ever having used photosensitizing ADs (aHR = 1·17, 95% CI 1·07-1·28) and ever having used ADs of unknown photosensitizing potential (aHR = 1·11, 95% CI 1·02-1·20), whereas no association was seen with ever having used nonphotosensitizing ADs (aHR = 0·99; 95% CI 0·91-1·07). Additionally, there was a modest increased risk with an increased number of prescriptions for photosensitizing ADs (aHR = 1·12, 95% CI 1·02-1·24; aHR = 1·19, 95% CI 1·06-1·34; aHR = 1·41, 95% CI 1·20-1·67 for one to seven, eight to 15 and ≥ 16 fills, respectively).

Conclusions: These findings provide moderate support for an increased cSCC risk among individuals treated with photosensitizing ADs.

Abstract Video

Antihypertensive drug use and cSCC risk, K.A. Su et al


Source: British Journal of Dermatology

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.16713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223125PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
November 2018
213 Reads

Article Mentions


Provided by Crossref Event Data
twitter
Twitter: Nicolasmoyag
January 6, 2019, 1:53 am EST
twitter
Twitter: BrJDermatol
November 9, 2018, 8:30 pm EST
twitter
Twitter: Ducrest
November 5, 2018, 12:57 pm EST

Publication Analysis

Top Keywords

photosensitizing ads
16
ads ahr
12
ads
9
photosensitizing
9
squamous cell
8
risk cutaneous
8
cutaneous squamous
8
cscc risk
8
cell carcinoma
8
95%
7
cscc
6
risk
6
ahr
6
membership history
4
health plan
4
plan membership
4
length health
4
healthcare utilization
4
keratosis survey
4
survey year
4

References

(Supplied by CrossRef)
Mechanisms of photosensitization induced by drugs: a general survey
Quintero et al.
Ars Pharm 2000
Drug-induced photosensitivity
Zuba et al.
Acta Dermatovenerol Croat 2016
Photosensitizing medications and photocarcinogenesis
O'Gorman et al.
Photodermatol Photoimmunol Photomed 2014
Photocarcinogenicity of drugs
Stern et al.
Toxicol Lett 1998

Similar Publications